Trials / Unknown
UnknownNCT05855590
Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements
Efficacy of Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements at Centro Medico de Occidente'
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Instituto Mexicano del Seguro Social · Other Government
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Tranexamic acid in debridement surgery of burns on the volume of bleeding in transfusion requirements
Detailed description
A randomized, double-blind, prospective trial was conducted to establish the effect of intraoperative tranexamic acid in the early surgical debridement of severe burns. The study was carried out between the months of January 2022 and December 2023.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic acid | 10mg/kg intravenous single dose |
| OTHER | 0.9% isotonic saline solution | 100 ml intravenous single dose |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2022-01-01
- Completion
- 2023-12-30
- First posted
- 2023-05-11
- Last updated
- 2023-05-11
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT05855590. Inclusion in this directory is not an endorsement.